NCT04354246 2025-05-22COM902 (A TIGIT Inhibitor) in Subjects With Advanced MalignanciesCompugen LtdPhase 1 Active not recruiting110 enrolled
NCT03302403 2020-10-08Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant TumorsFirst Affiliated Hospital of Wenzhou Medical UniversityPhase NA Unknown18 enrolled
NCT00036790 2019-12-17Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerUniversity of Wisconsin, MadisonPhase 1 Completed
NCT00948961 2016-06-27A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Celldex TherapeuticsPhase 1/2 Completed70 enrolled
NCT00024063 2013-12-19SU006668 in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Unknown
NCT00475956 2010-04-15Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursAstraZenecaPhase 1 Completed40 enrolled